search
Back to results

Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease

Primary Purpose

Dyspnea

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Dyspnea Neuroscience education
Usual care
Sponsored by
Cardenal Herrera University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dyspnea focused on measuring Education, Neuroscience education

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnostic of COPD by a physician or pneumologist
  • Stage 1, 2 or 3 on the GOLD Classification
  • GOLD Stage and FEV1 assessed by a physician in the last three months
  • Access to a computer and internet

Exclusion Criteria:

  • Cognitive impairment (MoCA-S score < 21)
  • Depression disorder (PHQ-9 score ≥11)
  • Generalized Anxiety Disorder (GAD-7 score ≥10)
  • Instable comorbidities preventing physical activities
  • Had a surgery in the past three months
  • Had an exacerbation in the past three months
  • Currently quitting tobacco
  • Use of oxygenation

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Dyspnea Neuroscience education

    Usual care

    Arm Description

    Outcomes

    Primary Outcome Measures

    Change from Perception of Dyspnea questionnaire at 4 and weeks and 6 months
    Change from disability questionnaire at 4 and weeks and 6 months
    Change from Quality of Life about respiratory disease questionnaire at 4 and weeks and 6 months
    Change from Level of Physical Activity questionnaire at 4 and weeks and 6 months
    Change from Activity-related intensity and unpleasantness of perceived dyspnea questionnaire at 4 and weeks and 6 months
    Change from Self-efficacy Scale for Physical Activity questionnaire at 4 and weeks and 6 months

    Secondary Outcome Measures

    Change from Forced vital capacity physiological parameter at 4 and weeks and 6 months
    Change from FEV1 physiological parameter at 4 and weeks and 6 months
    Change from Six Minute Walk Test (Sp02% Change) physiological parameter at 4 and weeks and 6 months

    Full Information

    First Posted
    July 15, 2021
    Last Updated
    August 3, 2021
    Sponsor
    Cardenal Herrera University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04987125
    Brief Title
    Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease
    Official Title
    Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 1, 2021 (Anticipated)
    Primary Completion Date
    April 1, 2022 (Anticipated)
    Study Completion Date
    May 1, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Cardenal Herrera University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The principal aim of this study was to adapt pain neuroscience education to dyspnea, Dyspnea Neuroscience Education (DNE), and measure its effect on dyspnea perception, physica l activity level, disability, quality of life and ventilatory and functional capacity through a randomized controlled trial. The secondary objectives were to evaluate its feasibility and its effect on emotional state (anxiety and depression), medical atten dance, number of exacerbations and the willingness to exercise.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dyspnea
    Keywords
    Education, Neuroscience education

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Dyspnea Neuroscience education
    Arm Type
    Experimental
    Arm Title
    Usual care
    Arm Type
    Active Comparator
    Intervention Type
    Behavioral
    Intervention Name(s)
    Dyspnea Neuroscience education
    Intervention Description
    Patients will follow an online therapeutic education course about dyspnea. Education about the cognitive and emotional aspects of dyspnea processing, with the goal of changing maladaptive cognitions and behaviors. The course will be group-based (5 participants). The frequency will be of 1 session per week for 4 weeks, each session will have a duration of 1 hour.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Usual care
    Intervention Description
    General health advice, physiotherapy treatment. The frequency will be of 1 session per week for 4 weeks, each session will have a duration of 1 hour.
    Primary Outcome Measure Information:
    Title
    Change from Perception of Dyspnea questionnaire at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Title
    Change from disability questionnaire at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Title
    Change from Quality of Life about respiratory disease questionnaire at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Title
    Change from Level of Physical Activity questionnaire at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Title
    Change from Activity-related intensity and unpleasantness of perceived dyspnea questionnaire at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Title
    Change from Self-efficacy Scale for Physical Activity questionnaire at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Secondary Outcome Measure Information:
    Title
    Change from Forced vital capacity physiological parameter at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Title
    Change from FEV1 physiological parameter at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).
    Title
    Change from Six Minute Walk Test (Sp02% Change) physiological parameter at 4 and weeks and 6 months
    Time Frame
    Preintervention, postintervention (4 weeks) and follow-up (6 months).

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    99 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Diagnostic of COPD by a physician or pneumologist Stage 1, 2 or 3 on the GOLD Classification GOLD Stage and FEV1 assessed by a physician in the last three months Access to a computer and internet Exclusion Criteria: Cognitive impairment (MoCA-S score < 21) Depression disorder (PHQ-9 score ≥11) Generalized Anxiety Disorder (GAD-7 score ≥10) Instable comorbidities preventing physical activities Had a surgery in the past three months Had an exacerbation in the past three months Currently quitting tobacco Use of oxygenation
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Luis Suso-Martí, PhD
    Phone
    627819667
    Email
    luis.suso@gmail.com

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease

    We'll reach out to this number within 24 hrs